Cabaletta Bio, Inc.
CABA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $112,419 | $929,474 | $271,423 | $97,543 |
| - Cash | $163,962 | $193,238 | $81,607 | $122,222 |
| + Debt | $15,600 | $5,018 | $5,138 | $0 |
| Enterprise Value | -$35,943 | $741,254 | $194,954 | -$24,679 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$4,813 | -$1,426 | -$3,684 | -$733 |
| % Margin | – | – | – | – |
| EBITDA | -$110,303 | -$66,249 | -$49,291 | -$45,556 |
| % Margin | – | – | – | – |
| Net Income | -$115,864 | -$67,675 | -$52,975 | -$46,289 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.34 | -1.65 | -1.81 | -1.8 |
| % Growth | -41.8% | 8.8% | -0.6% | – |
| Operating Cash Flow | -$88,222 | -$53,549 | -$46,380 | -$34,109 |
| Capital Expenditures | -$2,211 | -$687 | -$2,453 | -$1,166 |
| Free Cash Flow | -$90,433 | -$54,236 | -$48,833 | -$35,275 |